Sagimet Biosciences (SGMT) Interest & Investment Income (2022 - 2026)
Sagimet Biosciences' (SGMT) quarterly Interest & Investment Income came in at -$112000.0 in Q1 2026, down 2.75% year-on-year from -$115169.8 in Q1 2025, and down 109.36% quarter-over-quarter from $1.2 million in Q4 2025.
Sagimet Biosciences (SGMT) Interest & Investment Income (2022 - 2026) Analysis & Trends
Sagimet Biosciences' Interest & Investment Income history runs 5 years deep, the most recent figure standing at -$112000.0 for Q1 2026.
- On a quarterly basis, Interest & Investment Income fell 2.75% year-over-year to -$112000.0 in Q1 2026; TTM through Mar 2026 was $2.5 million, a 6.34% increase from a year earlier, with the FY2025 full-year figure at $5.9 million, down 34.16% from the prior year.
- Interest & Investment Income retreated to -$112000.0 in Q1 2026 per SGMT's latest filing, from $1.2 million in the prior quarter.
- Across five years, Interest & Investment Income topped out at $2.0 million in Q4 2024 and bottomed at -$1.4 million in Q4 2023.
- The 5-year median for Interest & Investment Income is $42000.0 (2023), against an average of $300875.0.
- Biggest YoY gain for Interest & Investment Income was 402.29% in 2023; the steepest drop was 841.97% in 2023.
- Year by year, Interest & Investment Income stood at $193000.0 in 2022, then slumped by 841.97% to -$1.4 million in 2023, then surged by 239.25% to $2.0 million in 2024, then tumbled by 39.97% to $1.2 million in 2025, then plunged by 109.36% to -$112000.0 in 2026.
- Per Business Quant, the three latest SGMT Interest & Investment Income figures stand at -$112000.0 (Q1 2026), $1.2 million (Q4 2025), and $1.4 million (Q3 2025).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 27.66 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 114.80 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | -65.80 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | 44.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | 19.51 Mn |
| 10 | Sagimet Biosciences | 227.27 Mn | 227.27 Mn | - | -112,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -112,000.00 |
| Dec 31, 2025 | 1.20 Mn |
| Sep 30, 2025 | 1.43 Mn |
| Jun 30, 2025 | -45,000.00 |
| Mar 31, 2025 | -109,000.00 |
| Dec 31, 2024 | 1.99 Mn |
| Sep 30, 2024 | 464,000.00 |
| Jun 30, 2024 | -30,000.00 |
| Mar 31, 2024 | -23,000.00 |
| Dec 31, 2023 | -1.43 Mn |
| Sep 30, 2023 | 1.10 Mn |
| Jun 30, 2023 | 13,000.00 |
| Mar 31, 2023 | 71,000.00 |
| Dec 31, 2022 | 193,000.00 |
| Sep 30, 2022 | 218,000.00 |
| Jun 30, 2022 | -106,000.00 |